Stock Upgrades Today Highlight Top Picks

 TopRated
 
  TopRated
 
Follow  Message
 
 
 
TopRatedStocks uncovering top-rated companies. Providing quick insights and recommendations, they help investors discover high-potential stocks based on robust metrics.
 

•  02 Dec 2025
 

•   AMZN  
   
  -0.25%
•   AREC  
   
  +2.51%
•   ARWR  
   
  -1.48%
•   AVGO  
   
  -0.12%
•   AXGN  
   
  -1.21%

$AMZN Amazon continues to capture analyst attention as Oppenheimer maintains its Outperform recommendation, signaling strong confidence in its market position. The firm price target implies a notable upside of 25.84%, reflecting optimism in Amazon continued dominance in e-commerce and cloud services.

$AREC American Resources receives a vote of confidence from D. Boral Capital, maintaining a Buy rating with an impressive 97.88% upside potential. This substantial forecast underscores the attractive positioning in the energy and resource market, suggesting significant near-term growth opportunities.

$ARWR Arrowhead Pharmaceuticals remains on a Buy path according to B of A Securities, although the forecast shows a 10.17% downside. Despite the slight projected pullback, Arrowhead innovative pipeline in RNA-based therapies continues to attract attention, making it a long-term play for biotech-focused traders who can tolerate near-term fluctuations.

$AVGO Broadcom sees continued support from both B of Securities and UBS, with each affirming a Buy recommendation and a modest 2.79% upside. Broadcom stable enterprise and semiconductor footprint positions it as a steady choice for traders seeking incremental gains within the tech hardware space.

$AXGN Axogen enters the spotlight as Mizuho initiates coverage with an Outperform rating and a 2.45% upside. The focus on peripheral nerve repair technologies highlights niche growth potential.

$BLTE Belite Bio faces challenges as HC Wainwright & Co. maintains its Buy stance despite a 24.39% downside forecast.

$CDRE Cadre Holdings draws renewed analyst confidence following its sixth acquisition, reinforcing Roth MKM Buy recommendation with a target of $49.

$CEVA gains traction as Loop Capital initiates coverage with a Buy rating and a striking 61.29% upside. The semiconductor IP offerings signal potential in high-growth technology markets, making it a compelling pick for tech-oriented traders.

$CHYM Chime Financial benefits from Goldman Sachs upgrade from Neutral to Buy, reflecting a 45.03% upside. As a growing fintech player, Chime continues to capitalize on digital banking trends, providing strong growth narrative.

$CNTB Connect Biopharma commands attention with a staggering 179.77% upside as Lake Street initiates coverage with a Buy rating. This depositary receipt reflects immense investor optimism in its innovative pipeline, offering one of the most aggressive near-term opportunities among upgrades.

$COST Costco Wholesale retains its Outperform rating at Telsey Advisory Group with a 17.96% upside, highlighting the robust retail performance and loyal membership base, which make it a reliable choice for more conservative traders.

$CRWD CrowdStrike continues to hold a Buy rating ahead of earnings, emphasizing confidence in its cybersecurity leadership and recurring revenue model, which can support steady investor returns.

$CVNA Carvana catches UBS eye with a Buy initiation and 13.17% upside. The used car platform shows potential for growth despite industry headwinds, appealing to interested in digital marketplaces.

$CVX Chevron sees an upgrade from HSBC from Hold to Buy, with a 15.26% upside. The energy giant remains well-positioned amidst evolving oil markets, balancing dividend stability with growth potential.

$FLUT Flutter Entertainment maintains a Buy at Benchmark with a 58.00% upside. The sports betting and online gaming portfolio continues to drive robust growth, capturing investor interest in regulated gaming markets.

$FNV Franco-Nevada maintains a Buy rating with a modest 5.03% upside. The gold-focused royalty company offers defensive exposure for traders looking to hedge against market volatility.

$INSM Insmed remains an Outperform at Mizuho despite a 2.46% downside, reflecting a steady pipeline and niche biotech positioning.

$KGC Kinross Gold retains a Buy rating with a small 5.06% upside. As a precious metals play, it offers a defensive option for traders seeking commodity-linked returns.

$KIM Kimco Realty benefits from a 21.00% upside as Argus Research reiterates its Buy stance. The REIT stable income and recovery in retail leasing make it an attractive dividend-focused option.

$MA Mastercard continues to receive a positive outlook from Bernstein with a Buy rating, supported by strong global payments trends and a price target of $607.

$MAS Masco Corporation retains a Buy rating from Argus, though the price target was slightly trimmed to $80. The industrial manufacturer transformation and operational efficiency provide steady, if modest, growth prospects.

$MRVL Marvell Technology maintains a Buy at Rosenblatt with a 0.61% upside, signaling stability on data infrastructure growth.

$NET Cloudflare initiates coverage with a Buy rating, highlighting opportunities in cybersecurity and network services, though specific price targets suggest modest near-term gains.

$NVDA Nvidia remains a strong Buy as analysts praise its unrivaled technology leadership. The company continues to dominate AI-driven chip markets, making it a top growth play in tech.

$OSIS OSI Systems maintains a Buy at Roth Capital with a 10.53% upside. The security and inspection solutions provider benefits from steady defense and commercial demand, providing a stable growth trajectory.

$PAAS Pan American Silver retains a Buy at B of A Securities despite a 17.59% downside. Traders should consider this as a longer-term play in precious metals with commodity-driven volatility.

$POST Post Holdings remains Outperform at Mizuho with a 28.21% upside, reflecting confidence in its food and consumer products portfolio amid steady demand.

$PRTA Prothena attracts attention with an 81.99% upside as Citizens maintains a Market Outperform rating, underscoring excitement around its biotech pipeline and potential breakthroughs.

$RBRK Rubrik holds a Buy at Guggenheim with a 71.16% upside. The data management and cloud solutions provider remains well-positioned in enterprise IT, offering compelling near-term growth.

$RDNT RadNet maintains a Buy at B. Riley Securities with a 7.65% upside. The diagnostic services provider offers steady healthcare sector exposure with moderate growth potential.

$SCHW Charles Schwab benefits from a Buy at Barclays with a $115 price target. The brokerage focus on low-cost investing and robust client growth supports its dividend and stability appeal.

$SFIX Stitch Fix retains a Market Perform at Telsey Advisory Group with a 24.97% upside, suggesting cautious optimism in the evolving online retail and personal styling sector.

$SNOW Snowflake continues its Buy rating at Rosenblatt with an 8.23% upside. The cloud data platform remains a strong play for enterprise adoption trends.

$STGW Stagwell maintains a Buy at Rosenblatt with a 58.92% upside. Its marketing and digital services portfolio position it for significant growth in the evolving advertising landscape.

$STNG Scorpio Tankers holds a Buy at B of A Securities with a 35.98% upside, benefiting from shipping market dynamics and strategic fleet positioning.

$STTK Shattuck Labs sees an upgrade from HC Wainwright & Co. from Neutral to Buy, with a 26.45% upside, highlighting innovation and growth potential in biotechnology applications.

$TELA TELA Bio emerges as a standout with a staggering 327.30% upside under Lake Street Buy rating, reflecting exceptional near-term opportunity and a highly bullish outlook for the regenerative medicine sector.

$TER Teradyne experiences upgrades at Stifel based on AI testing market potential, emphasizing the leverage in automation and semiconductor testing technologies.

$TMO Thermo Fisher Scientific upgrades from Hold to Buy at HSBC, showing a 6.84% upside. Its leading life sciences instruments and solutions maintain steady growth and investor appeal.

$TMUS T-Mobile benefits from a Buy upgrade, reflecting bullish sentiment in wireless communications and market expansion potential.

$TOST Toast sees a notable upgrade from BNP Paribas Exane from Neutral to Outperform with a 39.93% upside, highlighting opportunities in the digital restaurant management and payments space.

$TT Trane Technologies receives a Buy upgrade from BofA with a higher price target of $550, emphasizing strength in HVAC solutions and industrial growth potential.

$U Unity Software is upgraded to Buy by Arete Research with a 1.20% upside, signaling confidence in its gaming and real-time 3D platform leadership.

$ULTA Ulta Beauty maintains an Outperform rating with a 7.81% upside, reflecting steady growth in cosmetics retail and customer loyalty trends.

$UNH UnitedHealth Group retains Buy status at Wells Fargo with a $400 price target. Its strong healthcare services portfolio and dividend appeal make it attractive for risk-conscious investors.

$UNP Union Pacific maintains a Buy rating at Bernstein with a $290 price target. The industrial powerhouse benefits from infrastructure demand and stable freight operations.

$V Visa continues a Buy rating at Jefferies with a $410 price target. The payments giant remains a cornerstone for investors seeking dividend growth and exposure to digital payments.

$VTR Ventas maintains a Buy at Wells Fargo with an $88 price target. The healthcare-focused REIT offers steady income and exposure to the real estate sector.

$WELL Welltower retains a Buy rating at Wells Fargo with a $218 price target, providing another solid dividend and real estate income option.

$WWD Woodward holds a Buy at UBS with a modest 0.69% upside. Its aerospace and industrial control solutions offer defensive exposure with incremental growth potential.

$ZS Zscaler continues a Buy rating at Citigroup with a 37.53% upside. Its cloud security solutions remain in demand, presenting a strong growth-oriented tech play.

View All Headlines